Top compounds associated with response to MAML3


Feature Type Standardized
Nominal ANOVA
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA indisulam CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.19 9e-07
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Axitinib CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-06
Download CSV